Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Desmopressin Acetate Patent Expiration

Desmopressin Acetate was first introduced by Ferring Pharmaceuticals Inc in its drug Ddavp on Approved Prior to Jan 1, 1982. Other drugs containing Desmopressin Acetate are Ddavp (Needs No Refrigeration), Concentraid, Desmopressin Acetate, Stimate (Needs No Refrigeration), Stimate, Noctiva, Nocdurna, Minirin. 25 different companies have introduced drugs containing Desmopressin Acetate.


Desmopressin Acetate Patents

Given below is the list of patents protecting Desmopressin Acetate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Noctiva US11419914 Safe desmopressin administration Jun 15, 2030 Acerus Pharms
Noctiva US12090190 Safe desmopressin administration Jun 15, 2030 Acerus Pharms
Noctiva US9539302 Safe desmopressin administration Jun 15, 2030 Acerus Pharms
Nocdurna US9974826 Methods comprising desmopressin Apr 13, 2030 Ferring Pharms Inc
Nocdurna US10137167 Methods comprising desmopressin May 21, 2029 Ferring Pharms Inc
Nocdurna US11020448 Methods comprising desmopressin May 21, 2029 Ferring Pharms Inc
Nocdurna US11963995 Methods comprising desmopressin May 21, 2029 Ferring Pharms Inc
Noctiva US7799761 Pharmaceutical compositions including low dosages of desmopressin Sep 26, 2024

(Expired)

 Acerus Pharms
Nocdurna US7560429 Orodispersible dosage forms of desmopressin acetate Feb 02, 2024

(Expired)

 Ferring Pharms Inc
Nocdurna US7947654 Pharmaceutical formulations Dec 29, 2023

(Expired)

 Ferring Pharms Inc
Nocdurna US8802624 Methods of treatment using orodispersible desmopressin pharmaceutical formulations Dec 29, 2023

(Expired)

 Ferring Pharms Inc
Nocdurna US10307459 Pharmaceutical formulations of desmopressin May 07, 2023

(Expired)

 Ferring Pharms Inc
Nocdurna US9220747 Methods using desmopressin acetate in orodispersible form May 07, 2023

(Expired)

 Ferring Pharms Inc
Nocdurna US9504647 Pharmaceutical formulations of desmopressin May 07, 2023

(Expired)

 Ferring Pharms Inc
Nocdurna US9919025 Pharmaceutical formulations of desmopressin May 07, 2023

(Expired)

 Ferring Pharms Inc
Noctiva US7405203 Pharmaceutical compositions including low dosages of desmopressin May 06, 2023

(Expired)

 Acerus Pharms
Noctiva US7579321 Pharmaceutical compositions including low dosages of desmopressin May 06, 2023

(Expired)

 Acerus Pharms
Ddavp US7022340 Pharmaceutical composition as solid dosage form and method for manufacturing thereof Apr 30, 2023

(Expired)

 Ferring Pharms Inc
Desmopressin Acetate US7022340 Pharmaceutical composition as solid dosage form and method for manufacturing thereof Apr 30, 2023

(Expired)

 Ferring
Ddavp US5674850 High purity desmopressin produced in large single batches Dec 23, 2013

(Expired)

 Ferring Pharms Inc
Ddavp (needs No Refrigeration) US5674850 High purity desmopressin produced in large single batches Dec 23, 2013

(Expired)

 Ferring Pharms Inc
Ddavp US5500413 Process for manufacture of 1-deamino-8-D-arginine vasopressin Jun 29, 2013

(Expired)

 Ferring Pharms Inc
Ddavp US5763407 High-purity desmopressin produced in large single batches Jun 29, 2013

(Expired)

 Ferring Pharms Inc
Ddavp (needs No Refrigeration) US5482931 Stabilized pharmaceutical peptide compositions Jun 29, 2013

(Expired)

 Ferring Pharms Inc
Ddavp (needs No Refrigeration) US5500413 Process for manufacture of 1-deamino-8-D-arginine vasopressin Jun 29, 2013

(Expired)

 Ferring Pharms Inc
Ddavp (needs No Refrigeration) US5763407 High-purity desmopressin produced in large single batches Jun 29, 2013

(Expired)

 Ferring Pharms Inc



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Desmopressin Acetate's patents.

Given below is the list recent legal activities going on the following patents of Desmopressin Acetate.

Activity Date Patent Number
Patent litigations
Expire Patent
Critical
 30 Apr, 2018 US7022340(Litigated)
Maintenance Fee Reminder Mailed
Critical
 13 Nov, 2017 US7022340(Litigated)
Change in Power of Attorney (May Include Associate POA)
Critical
 30 May, 2014 US7022340(Litigated)
Recordation of Patent Grant Mailed
Critical
 04 Apr, 2006 US7022340(Litigated)
Patent Issue Date Used in PTA Calculation
Critical
 04 Apr, 2006 US7022340(Litigated)
Issue Notification Mailed
Critical
 15 Mar, 2006 US7022340(Litigated)
Dispatch to FDC 03 Mar, 2006 US7022340(Litigated)
Printer Rush- No mailing 02 Feb, 2006 US7022340(Litigated)
Mail Miscellaneous Communication to Applicant 02 Feb, 2006 US7022340(Litigated)
Miscellaneous Communication to Applicant - No Action Count 31 Jan, 2006 US7022340(Litigated)


Desmopressin Acetate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Desmopressin Acetate Generic API Manufacturers

Several generic applications have been filed for Desmopressin Acetate. The first generic version for Desmopressin Acetate was by Meitheal Pharmaceuticals Inc and was approved on Oct 15, 1997. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Mar 21, 2024.

Given below is the list of companies who have filed for Desmopressin Acetate generic, along with the locations of their manufacturing plants worldwide.


1. ABHAI LLC

Abhai Llc has filed for 2 different strengths of generic version for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Abhai Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1MG

tablet Prescription ORAL AB Jan 28, 2019
0.2MG

tablet Prescription ORAL AB Jan 28, 2019





2. ACTAVIS LABS FL INC

Actavis Laboratories Fl Inc has filed for 2 different strengths of generic version for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG

tablet Discontinued ORAL N/A Jul 1, 2005
0.1MG

tablet Discontinued ORAL N/A Jul 1, 2005





3. AM REGENT

American Regent Inc has filed for 1 generic for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Am Regent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.004MG/ML

injectable Discontinued INJECTION N/A Feb 14, 2019





4. APOTEX

Apotex Inc has filed for 3 different strengths of generic version for Desmopressin Acetate. Out of these 0.01mg/spray version comes by the name DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION). Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.01MG/SPRAY

(reference standard)

spray, metered Prescription NASAL AB Jan 27, 2005
0.1MG

tablet Prescription ORAL AB Mar 7, 2006
0.2MG

tablet Prescription ORAL AB Mar 7, 2006


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Richmond Hill Apotex Inc.
Brantford Apotex Pharmachem Inc.
Toronto Apotex Inc.
Etobicoke Apotex, Inc.
North York Apotex Inc.
Winnipeg Apotex Fermentation Inc.
India
Bengaluru Apotex Research Private Limited
Bangalore Apotex Pharmachem India Pvt Ltd.
Bangalore Apotex Research Private Limited - Bioequivalence Centre





5. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG

tablet Prescription ORAL AB Mar 21, 2024
0.1MG

tablet Prescription ORAL AB Mar 21, 2024


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Sangareddy Aurobindo Pharma Limited
Medchal Aurobindo Pharma Ltd
Bachupally Aurobindo Pharma Limited
United States
East Windsor Aurobindo Pharma USA Inc





6. BAUSCH

Bausch Health Us Llc has filed for 1 generic for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Bausch.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.01MG/SPRAY

(reference standard)

spray, metered Prescription NASAL AB Jan 25, 1999


Manufacturing Plant Locations
New

Bausch's manufacturing plants are situated in 2 countries - United States, Canada. Given below are the details of these plant locations as well as the firm names of Bausch as present at those locations.

Country City Firm Name
United States
Lancaster Bausch & Lomb Incorporated
Saint Louis Bausch & Lomb Inc
Petaluma Bausch Health Americas, Inc.
Rochester Bausch Health Americas, Inc.
Woodruff Bausch & Lomb Inc
Bridgewater Bausch and Lomb, Inc
Rancho Cucamonga Bausch and Lomb, Incorporated
Irvine Bausch and Lomb, Incorporated
Manchester Bausch & Lomb, Inc.
Wilmington Bausch & Lomb Incorporated
Rochester Bausch & Lomb Incorporated
Greenville Bausch & Lomb Incorporated
Bridgewater Bausch Health Companies, Inc.
Canada
Laval Bausch Health Companies Inc.
Steinbach Bausch Health Companies Inc.





7. BEDFORD

Bedford Laboratories Div Ben Venue Laboratories Inc has filed for 1 generic for Desmopressin Acetate. This 0.004mg/ml version comes by the name DESMOPRESSIN ACETATE PRESERVATIVE FREE. Given below are the details of the strengths of this generic introduced by Bedford.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.004MG/ML

injectable Discontinued INJECTION N/A Feb 18, 2000


Manufacturing Plant Locations
New

Bedford's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bedford as present at those locations.

Country City Firm Name
United States
Curryville Bedford Farm Bureau Cooperative
Bedford Bedford Research Foundation, Inc.
Shelbyville Bedford Cheese Store Inc





8. DR REDDYS

Dr Reddys Laboratories Ltd has filed for 1 generic for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.004MG/ML

injectable Prescription INJECTION AP Aug 19, 2022





9. GLAND

Gland Pharma Ltd has filed for 1 generic for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Gland.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.004MG/ML

injectable Prescription INJECTION AP Mar 20, 2023


Manufacturing Plant Locations
New

Gland's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Gland as present at those locations.

Country City Firm Name
India
Hyderabad Gland Pharma Limited
Malur Gland Chemicals Pvt Ltd.
Sriperumbudur Gland Chemical Private Limited
Parawada, Visakhapatnam Gland Pharma Limited
Hyderabad Gland Pharma Limited, Units I+II Pashamylaram Site
Aurangabad Gland Chemical Private Limited
Visakhapatnam Gland Pharma Limited





10. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1MG

tablet Discontinued ORAL N/A May 28, 2015
0.2MG

tablet Discontinued ORAL N/A May 28, 2015





11. HERITAGE PHARMA

Heritage Pharma Labs Inc has filed for 2 different strengths of generic version for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Heritage Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1MG

tablet Prescription ORAL AB May 26, 2017
0.2MG

tablet Prescription ORAL AB May 26, 2017


Manufacturing Plant Locations
New

Heritage Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Heritage Pharma as present at those locations.

Country City Firm Name
United States
East Brunswick Heritage Pharmaceuticals Inc
East Brunswick Heritage Pharmaceuticals, Inc. DBA AVET Pharmaceutical LABS





12. HOSPIRA

Hospira Inc has filed for 1 generic for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Hospira.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.004MG/ML

injectable Discontinued INJECTION N/A Aug 28, 2000


Manufacturing Plant Locations
New

Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.

Country City Firm Name
Australia
Mulgrave Hospira Australia Pty Ltd.
United States
Lake Forest Hospira Inc
Rocky Mount Hospira, Inc.
Mcpherson Hospira, Inc., A Pfizer Company
Pleasant Prairie Hospira Worldwide, LLC d.b.a. Hospira, a Pfizer-owned Company
Morgan Hill Hospira Inc
Clayton Hospira, Inc.
Dominican Republic (the)
Haina, San Cristobal Hospira, Ltd.





13. IMPAX LABS INC

Impax Laboratories Inc has filed for 2 different strengths of generic version for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1MG

tablet Discontinued ORAL N/A Jan 25, 2006
0.2MG

tablet Discontinued ORAL N/A Jan 25, 2006





14. MEITHEAL

Meitheal Pharmaceuticals Inc has filed for 1 generic for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Meitheal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.004MG/ML

injectable Prescription INJECTION AP Oct 15, 1997





15. NATCO PHARMA USA

Natco Pharma Usa Llc has filed for 2 different strengths of generic version for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Natco Pharma Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1MG

tablet Discontinued ORAL N/A Jun 27, 2014
0.2MG

tablet Discontinued ORAL N/A Jun 27, 2014





16. NOVAST LABS

Novast Laboratories Ltd has filed for 2 different strengths of generic version for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Novast Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG

tablet Prescription ORAL AB Jun 6, 2019
0.1MG

tablet Prescription ORAL AB Jun 6, 2019





17. SAGENT PHARMS INC

Sagent Pharmaceuticals Inc has filed for 1 generic for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Sagent Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.004MG/ML

injectable Prescription INJECTION AP Aug 22, 2017





18. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 1 generic for Desmopressin Acetate. This 0.01mg/spray version comes by the name DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION). Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.01MG/SPRAY

spray, metered Discontinued NASAL N/A Dec 23, 2013


Manufacturing Plant Locations
New

Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.

Country City Firm Name
United States
Billerica Sun Pharmaceutical Industries, Inc.
Princeton SUN PHARMACEUTICAL INDUSTRIES INC
Lexington Sun Pharmaceutical Industries Inc
India
Vadodara Sun Pharmaceutical Industries Limited - Karkhadi
Malanpur, Bhind (District) Sun Pharmaceutical Industries Limited
Vadodara Sun Pharmaceutical Industries Ltd.
Kanchipuram Sun Pharmaceutical Industries Limited- Madhuranthagam
Baruch Sun Pharmaceutical Industries Ltd.
New Delhi Sun Pharmaceutical Industries Limited
Punjab Sun Pharmaceutical Industries, Inc.
Dadra Sun Pharmaceutical Industries Limited
Vadodara Sun Pharmaceutical Industries Ltd
Halol Sun Pharmaceutical Industries Ltd.
Mohali Sun Pharmaceutical Industries Limited
Gurugram Sun Pharmaceutical Industries Limited (prev. Ranbaxy)
Ahmednagar Sun Pharmaceutical Industries Limited
Bharuch Sun Pharmaceutical Industries Ltd





19. SUN PHARM INDS

Sun Pharmaceutical Industries Ltd has filed for 1 generic for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.01%

solution Discontinued NASAL N/A Apr 12, 2012





20. SUN PHARM INDS LTD

Sun Pharmaceutical Industries Ltd has filed for 1 generic for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.004MG/ML

injectable Discontinued INJECTION N/A Jan 25, 2013





21. UBI

Ubi Pharma Inc has filed for 1 generic for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Ubi.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.004MG/ML

injectable Prescription INJECTION AP Sep 17, 2020





22. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Desmopressin Acetate. This 0.01mg/spray version comes by the name DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION). Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.01MG/SPRAY

spray, metered Prescription NASAL AB Oct 3, 2017